Deborah Schachter has more than 20 years of combination product experience. In her current role, Dr. Schachter is responsible for the strategy development and execution of the combination product dossier content and standards for both small molecule and biologic drug product CTA and marketing application dossiers. Dr. Schachter, in collaboration with other Janssen stakeholders, directed the dossier development for a wide range of combination products that have achieved global approval. Prior to Janssen, Dr. Schachter was an R&D group leader at Ethicon and Depuy responsible for the development of combination products for orthopedic and sustained drug delivery applications. Dr. Schachter is the primary inventor on 6 US issued patents.